Walleye Trading
VIR icon

Walleye Trading’s Vir Biotechnology VIR Stock Holding History

Walleye Trading’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,940
Closed -$11.1K – 5302
2025
Q3 		$11.1K Buy
+1,940
New +$9.92K ﹤0.01% 4191
2025
Q2 		– Hold
0
– – – 5281
2023
Q3 		– Sell
-31,466
Closed -$772K – 5936
2023
Q2 		$772K Buy
+31,466
New +$790K 0.04% 2409
2023
Q1 		– Hold
0
– – – 6059
2022
Q1 		– Sell
-8,035
Closed -$336K – 6412
2021
Q4 		$336K Sell
8,035
-12,187
-60% -$477K 0.01% 3384
2021
Q3 		$880K Buy
+20,222
New +$875K 0.02% 2347
2021
Q1 		– Hold
0
– – – 5795
2020
Q4 		– Hold
0
– – – 5482

Other funds holding VIR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return